Healthcare -
Biotechnology - NASDAQ - BM
$ 19.98
0.503 %
$ 1.44 B
Market Cap
-166.5
P/E
KNSA - SHORT-TERM DEBT
Short-term Debt KNSA - Kiniksa Pharmaceuticals, Ltd.
2.25 M
LAST VALUE
-42.28%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR